Assessment of diagnostic accuracy of dopamine receptor imaging agent "Ioflupane" for the patients with parkinsonism

Assessment of diagnostic accuracy of dopamine receptor imaging agent "Ioflupane" for the patients with parkinsonism - Diagnostic accuracy of Ioflupane

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000017168

Enrollment

200

Registered

2015-04-20

Start date

2015-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinsonism

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Satisfying the following 2 conditions within 3 months. 1)Undergoing physical, laboratory and neuropsychological examinations by neurologist. 2)Undergoing Ioflupane imaging.

Exclusion criteria

Exclusion criteria: In case of declaration of non-participation.

Design outcomes

Primary

Measure	Time frame
Diagnostic accuracy of each disease with parkinsonism	—

Countries

Japan

Contacts

Public ContactAnri Inaki

Kanazawa University Hospital Department of Nuclear Medicine

henri@nmd.m.kanazawa-u.ac.jp076-265-2333

Outcome results